Atlas Trials

Efficacy of N-Acetylcysteine in Improving/Normalizing ALT & AST in Patients of NAFLD

Clinical trial NCT05576428 · UNKNOWN

Trial details

NCT number
NCT05576428
Sponsor
Dow University of Health Sciences
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
NAFLD
Start date
2022-11-01
Primary completion
2023-04-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.